Myelin Repair Foundation

The Myelin Repair Foundation (MRF) was created to address the systemic problems in medical research and commercial drug development that work against the rapid delivery of patient treatments. The MRF’s Accelerated Research Collaboration™ (ARC™) model is a radical new process that recognizes the incentives and limitations of academic scientists, commercial biopharma, government regulators, and patients and their families, and fosters behavioral changes by adding tangible value to everyone. As a not-for-profit organization, the Myelin Repair Foundation is uniquely positioned to serve as an intermediary among these players with the rapid delivery of patient treatments as its singular focus.